4.7 Article

Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 120, Issue 3, Pages 441-446

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2016.05.014

Keywords

Cervical cancer; Image guided brachytherapy; Local control; Dose effect; Overall treatment time

Funding

  1. Elekta
  2. Varian Medical System
  3. Varian Medical System through Vienna Medical University
  4. Danish Cancer Society
  5. FP7 Programme [ICT-2011.5.2]
  6. The Danish Cancer Society [R108-A6854, R90-A5903, R125-A7753] Funding Source: researchfish

Ask authors/readers for more resources

Background and purpose: Currently, there is no consensus on dose prescription in image guided adaptive brachytherapy (IGABT) in locally advanced cervical cancer. The purpose of this study was to provide evidence based recommendations for tumor dose prescription based on results from a multi-center patient series (retroEMBRACE). Materials and methods: This study analyzed 488 locally advanced cervical cancer patients treated with external beam radiotherapy +/- chemotherapy combined with IGABT. Brachytherapy contouring and reporting was according to ICRU/GEC-ESTRO recommendations. The Cox Proportional Hazards model was applied to analyze the effect on local control of dose-volume metrics as well as overall treatment time (OTT), dose rate, chemotherapy, and tumor histology. Results: With a median follow up of 46 months, 43 local failures were observed. Dose (D90) to the High Risk Clinical Target Volume (CTVHR) (p = 0.022, HR = 0.967 per Gy) was significant for local control, whereas increasing CTVHR volume (p = 0.004, HR =1.017 per cm(3)), and longer OTT (p = 0.004, HR = 1.023 per day) were associated with worse local control. Histology (p = 0.084), chemotherapy (p = 0.49) and dose rate (p = 1.00) did not have significant impact on local control. Separate analyses according to stage of disease showed that dose to CTVHR, residual gross tumor volume (GTV(res)),and Intermediate Risk CTV (CTVIR) has significant impact on local control. Conclusion: CTVHR dose of >= 85 Gy (D90) delivered in 7 weeks provides 3-year local control rates of >94% in limited size CTVHR (20 cm(3)), >93% in intermediate size (30 cm(3)) and >86% in large size (70 cm(3)) CTVHR. CTVIR and GTV(res) dose of >= 60 Gy and >= 95 Gy (D98) leads to similar local control. A dose of 5 Gy (CTVHR) is required to compensate an increase of OTT by one week. Increased CTVHR volume by 10 cm(3) requires additional 5 Gy for equivalent local control. (C) 2016 Published by Elsevier Ireland Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available